Mickle Travis C

Avg. Two Year Performance

(7%) Avg. Purchase Return
(4%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return2%(15%)(14%)(< 1%)(7%)
Purchase Success Rate4 of 82 of 81 of 82 of 81 of 8
Average Sale Return----------
Sale Success Rate----------

Zevra Therapeutics, Inc.

Drugs » Biotechnology

President & CEO, Director:

Holdings: 171.77K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--